drug
as of 2026-07-01lamotrigine
Lamotrigine
MeSH D000077213
at a glance
small molecule
Pre-approval / investigational in the US
Developed by GlaxoSmithKline
5 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
5
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
NCT01015586Phase 4Completed
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
NCT00086593Phase 3Completed
Clinical Study Of Schizophrenia in Both Men and Women
NCT00071747Phase 3Completed
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
NCT00012558—Completed
KOLs & investigators
5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
Helge Frieling, Prof., MD
personKOL score 5
Professor Gary Donohoe, Ph.D.
personKOL score 5
Michael C Davis, M.D., Ph.D.
personKOL score 5
Bryan K Tolliver, MD, PhD
personKOL score —